FitSpresso Review: Why Fitspresso Coffee Loophole Is Better Than Other Weight Loss Supplement in 2025? 
Celon Pharma Hosting a Virtual Capital Markets Day on Wednesday, April 21st
KIELPIN, Poland, April 19, 2021 (GLOBE NEWSWIRE) -- Celon Pharma S.A. today announced that it will host a virtual Capital...
Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell
BOSTON and HOUSTON and TAIPEI, Taiwan, April 19, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq:...
Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline
New preclinical data from GLP toxicology and biodistribution study demonstrates in vivo safety of KB407 for cystic fibrosisCompany expands rare...
Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Program, Demonstrating Significant Seizure Suppression in Model of Focal Epilepsy
Data presented at American Academy of Neuroscience (AAN) Annual MeetingSAN FRANCISCO, April 19, 2021 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a...
New Research Confirms iCAD’s ProFound AI Aids Breast Cancer Detection with Digital Breast Tomosynthesis, Improves Radiologists’ Workflow
Studies presented at two leading breast imaging conferences demonstrate ProFound AI helps radiologists identify normal mammograms and those with increased...
World-Renowned Neurosurgeon Dr. Ben Carson, Sr. Joins Galectin Therapeutics as Special Consultant to Accelerate and Enhance Development of Company’s Galectin-3 Inhibitor, Belapectin
Galectin Therapeutics also announces new $10 million convertible debt financing from its Chairman, Richard E. UihleinNORCROSS, Ga., April 19, 2021...
Accolade to Announce Fiscal Fourth Quarter and Full Year 2021 Financial Results
SEATTLE, April 19, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better...
Catalyst Biosciences Announces Publication of CB 2679d Preclinical FIX Gene Therapy Data in Blood, the Journal of the American Society of Hematology
CB 2679d-GT significantly outperformed the R338L-Padua transgene after treatment with AAV-gene therapy in hemophilia B miceSOUTH SAN FRANCISCO, Calif., April 19,...
Daré Bioscience Appoints Dr. Sophia N. Ononye-Onyia to its Board of Directors
SAN DIEGO, April 19, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...
Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment
MONTREAL, April 19, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research,...
OVID Provides Update on OV101 Program and the Prioritization of its Resources
Completed Soticlestat Agreement with Takeda Provides Significant Resources to Advance and Enrich OVID’s Pipeline, Including OV882 for Angelman Syndrome Company...
Rezolute Announces $30 Million Debt Financing Agreement with SLR Capital Partners
REDWOOD CITY, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (Nasdaq: RZLT), a clinical stage...
Immutep Quarterly Activities Report
Highlights Safely dosed the last HNSCC patient for Stage 2 of Part C of the TACTI-002 Phase II study (also...
University of Miami Health System and One Medical Announce Affiliation Focused on Seamless Coordinated Care
One Medical plans to bring its technology-powered primary care model to FloridaMIAMI and SAN FRANCISCO, April 19, 2021 (GLOBE NEWSWIRE)...
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
2021: Executing on Opportunities and Preparing for the FutureFRAMINGHAM, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:...
CERiS Offers First Prepayment Dual Reviews For Payment Integrity Programs
Itemized Bill Review and DRG Validation Are Performed by a Division of a Publicly Traded Company, Independent from Ongoing Market...
Therma Bright Announces EU-CE Approval for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid(TM) Test Kits
New global distribution partner McWilliams Collective secures test kit order from European clientToronto, Ontario--(Newsfile Corp. - April 19, 2021) -...
Embark Delta Inc. Completes Additional Shipment to Province of Ontario
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
Embark Delta Inc. Completes First Shipment to Province of Saskatchewan
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
LivaNova Achieves Clinical Milestone in Heart Failure Program
300th patient randomized in ANTHEM-HFrEF pivotal study LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced...